#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16628	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2537	793.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1915	1915	T	1084	T,C,A,G	1078,4,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16628	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2537	793.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1649	1649	C	1040	C,T	1039,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16628	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2537	793.1	0	HET	.	.	.	A263G	.	263	263	A	728	728	A	915	A,G	491,424	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28630	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4212	848.4	0	.	n	.	0	C265T	SNP	265	265	C	1001	1001	T	1059	T,C,A,G	1049,4,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28630	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4212	848.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	2073	2073	A	1211	A,G	1210,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28630	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4212	848.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2707	2707	C	1035	C,T,A	1031,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28630	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4212	848.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2781	2781	A	985	A,G	983,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28630	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4212	848.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3333	3333	C	944	C,T,G	942,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	49616	blaTEM	861	861	100.0	blaTEM.l15.c30.ctg.1	2234	2773.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2512	folP	855	855	100.0	folP.l15.c4.ctg.1	2058	151.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1239	1241	AGC	255;254;256	A,G;G;C,G	254,1;254;255,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5398	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3798	177.2	1	SNP	p	S91F	0	.	.	271	273	TCC	824	826	TCC	209;206;206	T;C;C	209;206;206	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5398	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3798	177.2	1	SNP	p	D95N	0	.	.	283	285	GAC	836	838	GAC	202;204;203	G;A;C,T	202;204;202,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5398	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3798	177.2	1	SNP	p	D95G	0	.	.	283	285	GAC	836	838	GAC	202;204;203	G;A;C,T	202;204;202,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2214	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1888	146.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	752	754	ACC	197;197;199	A;C,T;C	197;196,1;199	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2214	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1888	146.3	0	.	p	.	0	L47P	NONSYN	139	141	CTC	776	778	CCC	208;216;219	C,G;C;C,T	207,1;216;218,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2214	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1888	146.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	950	952	CAC	293;293;289	C;A,G;C,A	293;292,1;287,2	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2214	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1888	146.3	1	SNP	p	G45D	0	.	.	133	135	GGC	770	772	GGC	204;205;204	G;G;C	204;205;204	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1262	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1370	114.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5412	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3512	192.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1795	1797	ATC	252;251;249	A;T;C	252;251;249	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5412	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3512	192.2	1	SNP	p	D86N	0	.	.	256	258	GAC	901	903	GAC	227;229;231	G;A,G;C	227;227,2;231	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5412	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3512	192.2	1	SNP	p	S87R	0	.	.	259	261	AGT	904	906	AGT	230;230;231	A;G;T	230;230;231	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5412	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3512	192.2	1	SNP	p	S87W	0	.	.	259	261	AGT	904	906	AGT	230;230;231	A;G;T	230;230;231	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5412	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3512	192.2	1	SNP	p	S87I	0	.	.	259	261	AGT	904	906	AGT	230;230;231	A;G;T	230;230;231	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5412	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3512	192.2	1	SNP	p	S88P	0	.	.	262	264	TCC	907	909	TCC	230;230;232	T;C;C,G	230;230;231,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5032	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3152	199.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1820	1822	GGC	242;239;241	G;G,T;C	242;238,1;241	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1526	1528	GCA	279;277;279	G;C,G;A	278;276,1;279	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1529	1531	ATC	280;277;279	A;T;C	280;277;279	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1541	1543	GTG	285;284;284	G,A;T;G,T	284,1;284;283,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1541	1543	GTG	285;284;284	G,A;T;G,T	284,1;284;283,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2045	2047	ACC	279;279;275	A,G;C,G;C,T	278,1;277,2;274,1	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2099	2101	GCG	269;269;269	G;C;G	269;269;269	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2099	2101	GCG	269;269;269	G;C;G	269;269;269	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2222	2224	GGC	245;242;241	G,T;G,A;C,A	244,1;241,1;240,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2231	2233	GGC	235;234;235	G;G;C	235;234;235	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4546	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	190.1	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2249	2251	TCG	239;243;245	T,G;C,T;G	236,3;242,1;245	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6390	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3538	225.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1828	1830	CCG	262;262;261	C,G;C,G;G,A	261,1;261,1;260,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2590	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2399	134.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	879	879	C	192	C	192	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	440	porB1a	984	100	95.0	porB1a.l15.c4.ctg.2	182	59.7	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	66;62;60	A;C;G	66;62;60	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	440	porB1a	984	100	95.0	porB1a.l15.c4.ctg.2	182	59.7	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	17;13;10	C;A;A	17;13;10	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	3600	porB1b	1041	1041	100.0	porB1b.l6.c4.ctg.1	2036	220.3	1	SNP	p	G120K	1	.	.	358	360	AAG	867	869	AAG	307;308;307	A,G;A;G,A	306,1;308;305,2	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	3600	porB1b	1041	1041	100.0	porB1b.l6.c4.ctg.1	2036	220.3	1	SNP	p	D121N	0	.	.	361	363	GAC	870	872	GAC	304;306;305	G,T;A;C	303,1;306;305	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	3600	porB1b	1041	1041	100.0	porB1b.l6.c4.ctg.1	2036	220.3	1	SNP	p	A121D	1	.	.	361	363	GAC	870	872	GAC	304;306;305	G,T;A;C	303,1;306;305	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11470	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5261	271.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2242	2244	CAT	271;271;272	C,T,A;A;T	269,1,1;271;272	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1882	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1531	153.3	1	SNP	p	V57M	1	.	.	169	171	ATG	750	752	ATG	329;326;326	A;T;G	329;326;326	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
